Nutriband Inc
$ 3.11
6.69%
07 Aug - close price
- Market Cap 35,434,700 USD
- Current Price $ 3.11
- High / Low $ 3.11 / 2.91
- Stock P/E N/A
- Book Value 0.49
- EPS -2.56
- Next Earning Report 2026-09-08
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.78 %
- ROE -1.46 %
- 52 Week High 8.63
- 52 Week Low 2.80
About
Nutriband Inc. develops a portfolio of transdermal pharmaceuticals. The company is headquartered in Orlando, Florida.
Analyst Target Price
$15.00
Quarterly Earnings
| Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | Jul 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-06-11 | 2026-04-29 | 2025-12-16 | 2025-09-09 | 2025-05-30 | 2025-04-28 | 2024-12-03 | 2024-09-03 | 2024-05-31 | 2024-04-30 | 2023-12-12 | 2023-09-11 |
| Reported EPS | -0.0796 | -0.04 | -0.32 | -2.12 | -0.12 | -0.51 | -0.1227 | -0.1542 | -0.2072 | -0.2295 | -0.2247 | -0.1059 |
| Estimated EPS | -1.89 | -1.89 | -2.13 | -0.17 | -0.16 | -0.12 | None | None | None | None | -0.06 | -0.07 |
| Surprise | 1.8104 | 1.85 | 1.81 | -1.95 | 0.04 | -0.39 | 0 | 0 | 0 | 0 | -0.1647 | -0.0359 |
| Surprise Percentage | 95.7884% | 97.8836% | 84.9765% | -1147.0588% | 25% | -325% | None% | None% | None% | None% | -274.5% | -51.2857% |
Next Quarterly Earnings
| Jul 2026 | |
|---|---|
| Reported Date | 2026-09-08 |
| Fiscal Date Ending | 2026-07-31 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: NTRB
2026-08-01 03:40:13
This article provides a technical analysis of Nutriband Inc (NTRB), detailing its price momentum, support and resistance levels, and indicator readings. It shows that NTRB's price momentum score is 3.42, ranking 165 out of 199 in its industry, and the stock is currently trading between resistance at $3.17 and support at $2.67. The analysis also summarizes various technical indicators and moving averages, providing "Sell" signals for most indicators and moving averages.
2026-07-31 14:40:13
This article provides an overview of Nutriband Inc. (NTRB), detailing its market trends, key financials, and analyst ratings. The company is engaged in developing transdermal pharmaceutical products, with a focus on abuse-deterrent technology, and analysts rate it as a "Buy" with significant upside potential despite recent stock market underperformance.
2026-07-31 02:39:56
This article provides a risk assessment for Nutriband Inc (NTRB), detailing its volatility, financial risk, and investment risk. NTRB has a risk assessment score of 2.17, ranking 158 out of 199 in the Healthcare Equipment & Supplies industry, and a beta value of 1.93, indicating higher volatility compared to the S&P 500. The report includes various metrics such as maximum drawdown, daily returns, Sharpe ratio, and liquidity.
2026-07-29 09:23:57
This article provides a revenue breakdown for Nutriband Inc. (NTRBW), detailing its top segments and regional performance. The primary contribution to revenue comes from the United States, which generated $2.03 million last year and $2.14 million the year prior.
2026-07-27 10:04:47
This article provides a detailed revenue breakdown for Nutriband Inc (NTRB), categorizing its revenue by business segments (Sale of goods, Services) and geographical regions (United States, Non-United States). As of the latest update, Nutriband Inc's revenue primarily comes from the sale of goods within the United States. The financial data is available up to FY2026Q3.
2026-07-27 09:12:52
This article provides a detailed quarterly and annual balance sheet for Nutriband Inc (NTRB), allowing investors to analyze the company's financial health, liquidity, leverage, and return on equity. It presents extensive financial data for various balance sheet items from FY2018Q1 to FY2027Q1. The content also includes an FAQ section addressing common questions about balance sheet metrics, the difference between assets, liabilities, and shareholders' equity, and specific figures for Nutriband Inc's cash, total liabilities, total assets, and shareholders' equity as of the latest reported quarter.
